Jiangsu Leeway Biological Technology Co., Ltd. announced that it has entered into agreement to issue common shares for gross proceeds of CNY 45,000,000 on September 17, 2021. The transaction include participation from returning investor Xinjiang Baihuacun Co., Ltd. to retain 100% stake in the company. The transaction has approved at the first meeting of the eighth session of the board of directors of the investor. The registered capital will increase from CNY 5,000,000 to CNY 50,000,000.